From innovative science to optimal health outcomes

Developing Medications that are Safe, Efficacious & Patient-friendly

Our research adopts a drug-product-patient tripartite approach to develop effective and safe drug delivery systems. The research programme aims to develop improved treatments for target diseases such as cancer, immunological, cardiovascular and neurological disorders. Such translational research entails the participation of our multi-disciplinary team of pharmaceutical scientists and clinical pharmacists who are experts in pharmaceutical chemistry, formulation science, pharmaceutical technology, biopharmaceutics, clinical pharmacy or pharmacy practice, as illustrated in the diagram below.

Click on the green or blue boxes to see the research groups working in that area.